课题基金 / 基金详情

Development of new functional glycans and the applications

Development of new functional glycans and the applications
新型功能聚糖的开发及应用
批准号:
05660386
负责人:
KISO Makoto
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

KISO Makoto的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have examined the molecular requirements of selectin recognition by use of a variety of synthetic carbohydrate analogues with specific modifications on the sialyl-Lewis X,a binding epitope of leukocyte-endothelial cell adhesion molecules (selectins). E- and L-Selectins require OH groups at c-2,3 and 4 of the L-fucose moiety, while p-selectin requires only oh-3. Modifications of the sialic acid moiety, except for the carboxyl group, have little effect on the binding of any of the selectins. All three selectins-bound efficiently to an sulpho-Lewis X analogue in which sialic acid and ceramide are replaced with the sulfate group and an artificial long-chain alkyl (B-30) , respectively. This molecule is now being examined for biomedical applications as an anti-inflammatory as well as anti-metastatic agent.It is of interest that a synthetic 2- (tetradecyl) hexadecyl 0- (5-acetamido-3,5-didoxy-D-glycero-alpha-D-galacto-2-nonulopyranosylonic acid) - (2-3) -0-beta-D-galactopyranosyl- (1-4) -beta-D-glucopyranoside, an analogue of ganglioside GM3, markedly inhibited the cellular immune response. This effect was quantitatively similar to that of cyclosporin A.
期刊论文(62)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Yoshida: "Synthesis of chemically modified sialic acid-containing sialyl-Lewis X ganglioside analogues recognized by the selectin family" Glycoconjugate J.10. 3-15 (1993)
M.Yoshida:“选择素家族识别的化学修饰的含唾液酸的唾液酸-Lewis X 神经节苷脂类似物的合成”Glycoconjugate J.10。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A. Kameyama: "Total synthesis of tumor-associated ganglioside, sialyl Lewis A" J. Carbohydr. Chem.13. 641-654 (1994)
A. Kameyama:“肿瘤相关神经节苷脂,唾液酸路易斯 A 的全合成”J. CarboHydr。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
28
    Development of DDS-carrier for BBB based onsialic acid
    • 批准号:
      22658038
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.37万
    • 财政年份:
      2010
    • 负责人:
      KISO Makoto
    • 依托单位:
    CREATION OF ARTIFICIAL COMPLEX CARBOHYDRATE PROBES AND MODULATION OF HIGHER BIOLOGICAL FUNCTIONS
    • 批准号:
      17101007
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $58.07万
    • 财政年份:
      2005
    • 负责人:
      KISO Makoto
    • 依托单位:
    Basic Research on Discovery and Functions of Novel Physiologically Active Complex Carbohydrates
    • 批准号:
      12306007
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $22.08万
    • 财政年份:
      2000
    • 负责人:
      KISO Makoto
    • 依托单位:
    Studies on high-dimensional functions of glycoconjugates toward development of new medicines and biomaterials
    • 批准号:
      10556026
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.03万
    • 财政年份:
      1998
    • 负责人:
      KISO Makoto
    • 依托单位:
    国内基金
    海外基金
    P-selectin介导砷烯的切缘靶向递送用于防治实体瘤术后复发与转移研究
    • 批准号:
      QN25H280042
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      罗利峰
    • 依托单位:
    CD43响应上皮细胞E-Selectin招募诱导Th17/Treg失衡导致儿童变应性鼻炎的机制研究
    • 批准号:
      MS25H130006
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      毕静
    • 依托单位:
    冠脉内皮细胞线粒体氧化磷酸化调控E-selectin表达在川崎病冠脉损 伤中的作用及机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      张丹凤
    • 依托单位:
    血小板P-Selectin/PSGL1调控乳腺癌发展转移的作用与机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      陈雪
    • 依托单位: